Are flexible hours or patient caseloads your biggest concern? Or is your practice setting what matters most?
This video reviews the impact of the SOFT/TEXT trials for the treatment of patients with premenopausal breast cancer, and ways to best use the results.
This video highlights trials studying the long-term impact of adjuvant tamoxifen and aromatase inhibitors for the treatment of patients with postmenopausal breast cancer.
In this interview we discuss the link between breast implants and anaplastic large-cell lymphoma, a rare type of T-cell lymphoma.
The AKT inhibitor ipatasertib offered improved progression-free survival over placebo when combined with paclitaxel in women with triple-negative breast cancer.
Participating in a palliative care consultation significantly decreased healthcare use of Medicare beneficiaries with advanced cancer at the end of life.
So-called “narrow network” healthcare plans are more likely to exclude oncologists who are associated with NCI-designated or NCCN Cancer Centers, according to a new study.
Pediatric patients with ALK-positive anaplastic large cell lymphomas and inflammatory myofibroblastic tumors had strong responses to treatment with crizotinib.
A novel ErbB inhibitor called pyrotinib was well tolerated and showed promising activity in patients with metastatic HER2-positive breast cancer, according to results of a phase I trial.
This video examines the use of molecular diagnostics for guiding adjuvant endocrine therapy in patients with breast cancer.